New Key Statistics Module, Z-Score and F-Score
SHSE:688513 Key Ratios
Market Cap ¥ M | 5,271.25 |
Enterprise Value ¥ M | 4,087.30 |
P/E(ttm) | 20.94 |
PE Ratio without NRI | 21.45 |
Forward PE Ratio | 15.63 |
Price/Book | 1.97 |
Price/Sales | 3.98 |
Price/Free Cash Flow | 47.32 |
Price/Owner Earnings | 77.75 |
Payout Ratio % | 0.42 |
Revenue (TTM) ¥ M | 1,307.00 |
EPS (TTM) ¥ | 1.43 |
Beneish M-Score | -1.88 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.80 |
y-y EBITDA Growth Rate % | 17.00 |
EV-to-EBIT | 15.40 |
EV-to-EBITDA | 15.40 |
PEG | 2.19 |
Shares Outstanding M | 176.53 |
Net Margin (%) | 19.12 |
Operating Margin % | 18.25 |
Pre-tax Margin (%) | 20.01 |
Quick Ratio | 2.65 |
Current Ratio | 2.93 |
ROA % (ttm) | 7.41 |
ROE % (ttm) | 9.50 |
ROIC % (ttm) | 13.66 |
Dividend Yield % | 2.00 |
Altman Z-Score | 5.72 |
SHSE:688513 Number of Guru Trades
SHSE:688513 Volume of Guru Trades
Gurus Latest Trades with SHSE:688513
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688513 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Easton Biopharmaceuticals Co Ltd Insider Transactions
No Available Data